22 May 2013
Keywords: roche, xeloda/paclitaxel, effective, anthracylcines, swiss, drug, major
Article | 12 June 2006
Swiss drug major Roche says that strong results were presented at the American Society of Clincial Oncology's annual meeting, held ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 2006
21 May 2013
© 2013 thepharmaletter.com